InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-5.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Ahlberg Gregory A, Chief Executive Officer. Insider active across 1 company, notably Abbott Laboratories. In total, 7 filings have been recorded. History available since 1 October 2021. The latest transaction was disclosed on 28 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
2,820 shares@ US$99.7723.5% of flowCommon shares without par valueSEC:0001415889-23-003886:0
9,504 shares0Common shares without par valueSEC:0001415889-23-003044:0
221 shares@ US$96.761.9% of flowCommon shares without par valueSEC:0001415889-22-010270:0
2,561 shares@ US$122.410.0001% mcap33.4% of flowCommon shares without par valueSEC:0001415889-22-002184:0
11,647 shares0Common shares without par valueSEC:0001415889-22-001728:0
6,000 shares@ US$48.980.0001% mcap30.6% of flowCommon shares without par valueSEC:0001415889-21-005270:0
220 shares@ US$118.130.0000% mcap2.7% of flowCommon shares without par valueSEC:0001415889-21-004754:0
7 of 7 declarations
About Ahlberg Gregory A
Gregory A. Ahlberg is the Chief Executive Officer at Abbott Laboratories. He oversees the company's operations and is responsible for growth strategy. His role is crucial to ensure Abbott's success in the pharmaceutical sector.
